Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors

A Single-center, Real-world Prospective Observational Study of the Incidence and Development of Anxiety and Depression in Patients With Malignant Tumors

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05596344

Enrollment

200

Registered

2022-10-27

Start date

2023-05-20

Completion date

2032-11-30

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Malignant Tumor

Brief summary

This study was a single-center prospective, real-world observational study with plans to enroll all eligible patients. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Detailed description

A total of 200 patients with malignant tumors will be enrolled in Henan Cancer Hospital. This study is a single-center prospective real-world observational study, and all eligible patients are planned to be enrolled. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Interventions

OTHERHospital Anxiety and Depression Scale

The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

1. Men and women of all ages are welcome. 2. Pathological diagnosis of malignant tumor in our hospital. 3. Received at least one hospitalization at this hospital. 4. The expected survival time is greater than 1 year.

Exclusion criteria

1.There was no pathological report of malignancy.

Design outcomes

Primary

Measure	Time frame	Description
Hospital Anxiety Depression Scale	Confirmed in 1 day	Confirmed in 1 day

Countries

China

Contacts

Primary ContactWang Jiaqiang, Dr

wjqwtj@126.com13592413731

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026